Kevin Eggan named a member of a new Stem Cell Research Consortium

March 26, 2013

HSCI's Kevin Eggan has been named a member of a new Stem Cell Research Consortium established by the Cure Alzheimer's Fund. The six consortium scientists, at academic research institutions in the US and Israel will be using techniques pioneered by Eggan, an HSCI Principal Faculty member and a professor in Harvard's Department of Stem Cell and Regenerative Biology, to study in the laboratory the neurons created from the cells of patients at high genetic risk of developing Alzheimer's.

This approach is one of our best shots at understanding common forms of Alzheimer’s and, once defects are identified, we can use these same brain cells to screen for new drugs,” said Sam Gandy, MD, PhD, the head of the Cure Alzheimer’s Fund Stem Cell Research Consortium. “It’s a huge breakthrough.